<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00638755</url>
  </required_header>
  <id_info>
    <org_study_id>C213</org_study_id>
    <nct_id>NCT00638755</nct_id>
  </id_info>
  <brief_title>The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Effect of Nasal Carbon Dioxide on Nasal Congestion Via Acoustic Rhinometry in Subjects With Perennial Allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capnia, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capnia, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of nasal CO2 on nasal congestion and
      other symptoms related to Perennial Allergic Rhinitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized study to evaluated the safety and effect of nasal carbon dioxide on nasal
      congestion using acoustic rhinometry in subjects with perennial allergic rhinitis. The
      acoustic rhinometry is an instrument that will be used to assess the levels of the nasal
      congestion in each subject. Approximately 20 men and women ages 19-65 years old who have a
      history consistent with perennial allergic rhinitis requiring pharmacology for at least 2
      years and meet all other eligibility criteria will be enrolled in this study. There will be
      six (6) visits to the clinic. There will be a screening visit, four (4) treatment visits, and
      an end of study visit. A subject's participation in the study may last up to 58 days. There
      will be four different doses given in this study. Each subject will receive 3 different doses
      of the study drug and one dose of the placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date>July 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the dose-related effects of CO2 on nasal congestion assessed by acoustic rhinometry.</measure>
    <time_frame>Baseline, Post Treatment: 15 mins, 30 mins, 45 mins, 1 hour, 2 hours, 3 hours, 4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in olfactory test scores post-treatment</measure>
    <time_frame>Baseline, Post Treatment: 1 hour &amp; 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNSS, TNNSS, and TSS comparisons at multiple timepoints</measure>
    <time_frame>Baseline, Post Treatment: 15 mins, 30 mins, 45 mins, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, 12 hours, 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Perennial Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The following treatment sequence: A (Nasal Carbon Dioxide), B (Nasal Carbon Dioxide), C (Nasal Carbon Dioxide), D (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The following treatment sequence: B (Nasal Carbon Dioxide), C (Nasal Carbon Dioxide), D (placebo), A (Nasal Carbon Dioxide)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The following treatment sequence: C (Nasal Carbon Dioxide), D (placebo), A (Nasal Carbon Dioxide), B (Nasal Carbon Dioxide)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The following treatment sequence: D (placebo), A (Nasal Carbon Dioxide), B (Nasal Carbon Dioxide), C (Nasal Carbon Dioxide)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal Carbon Dioxide</intervention_name>
    <description>Nasal Carbon Dioxide</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal Carbon Dioxide</intervention_name>
    <description>Nasal Carbon Dioxide</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal Carbon Dioxide</intervention_name>
    <description>Nasal Carbon Dioxide</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nasal Carbon Dioxide</intervention_name>
    <description>Nasal Carbon Dioxide</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a history consistent with minimal 2 year history of perennial allergic rhinitis
             requiring pharmacotherapy.

          -  Positive skin test to perennial allergens (e.g. cats, dogs, house dust mite, etc.)

          -  Females of childbearing potential must commit to using an acceptable method of birth
             control and have a negative pregnancy test

        Exclusion Criteria:

          -  History of asthma (other than mild or intermittent)

          -  Clinically significant nasal disorders

          -  Acute or significant sinusitis or upper respiratory infection within 14 days of
             randomization

          -  Have an existing serious medical condition (such as severe emphysema, other
             respiratory diseases, heart disease, etc.) that precludes participation in the study

          -  Use of certain medication s prior to randomization and during study participation

          -  Participation in prior study with Nasal CO2

          -  Participation in another clinical study within 30 days of planned randomization date
             and for the duration of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Capnia Clinical Study Investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capnia Investigative Site</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Capnia Investigative Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2008</study_first_submitted>
  <study_first_submitted_qc>March 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2008</study_first_posted>
  <disposition_first_submitted>August 17, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>August 17, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 19, 2010</disposition_first_posted>
  <last_update_submitted>August 17, 2010</last_update_submitted>
  <last_update_submitted_qc>August 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kristen Yen- Associate Director, Clinical</name_title>
    <organization>Capnia, Inc.</organization>
  </responsible_party>
  <keyword>Allergic Rhinitis</keyword>
  <keyword>Perennial Allergic Rhinitis</keyword>
  <keyword>Allergies to perennial allergens</keyword>
  <keyword>Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

